Overview

PET/CT Imaging for Radiation Dosimetry, Plasma Pharmacokinetics, Safety and Tolerability in Healthy Volunteers and Safety, Tolerability and Diagnostic Performance of BAY86-9596 in Patients With Non-small Cell Lung Cancer, Breast Cancer, Head and Nec

Status:
Completed
Trial end date:
2011-09-01
Target enrollment:
Participant gender:
Summary
Visual assessment of diagnostic PET/CT (positron emission tomography/computed tomography) images obtained after a single intravenous injection of BAY86-9596 in patients with cancer and inflammation
Phase:
Phase 1
Details
Lead Sponsor:
Life Molecular Imaging SA
Piramal Imaging SA
Treatments:
Fluorodeoxyglucose F18